hemaPEN technical information
Advanced precision microsampling
Confident and accurate results begin with hemaPEN.
hemaPEN® is a microsampling tool that enables the collection of four volumetrically fixed, accurate and precise, samples from a single source.
Where there is no option to compromise, the hemaPEN is designed to maintain sample integrity for quantitative analysis and enable information-rich decision making.
hemaPEN is an easy to use advanced precision microsampling tool that can be used by anyone in any place.
View available hemaPEN models for your location:
Australia and New Zealand Rest of world
Interested in hemaPEN and microsampling innovations?
Technical Poster - Improved dried blood spot-based metabolomics using a novel microsampling device
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490.
Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Poster - Blood sampling made easy
Download: Poster - Blood sampling made easy [PDF]
Author: Australian National Fabrication Facility (ANFF).
View full product details
Technical Poster - Volumetrically accurate samples via a novel dried blood spot sampling technique
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Technical Poster - Metabolomics/lipidomics of dried blood spots using a novel blood microsampling device (hemaPEN®)
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Technical Poster - Incorporating novel synthetic DBS substrates into a blood microsampling device for multi-omics analyses
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Technical Poster - Collection and storage of volumetrically accurate and precise dried blood spots in a contained device: hemaPEN
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
